Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.54 |
| ▸ | CCR8 | P51685 | 1/20 | 0.54 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | ADK | P55263 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197279 | 0.86 | NISCH (0.54) | CCR1CCR8NISCHMTORADK | |
| SCHEMBL13830975 | 0.86 | NISCH (0.39) | CCR1CCR8NISCHMTORADK | |
| SCHEMBL29079328 | 0.79 | NISCH (0.47) | CCR1CCR8NISCHMTORADK | |
| SCHEMBL14304159 | 0.78 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL3050014 | 0.78 | NISCH (0.46) | NISCHMTORADKMETAP2ALDH1A1 | |
| SCHEMBL4766313 | 0.78 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL31374443 | 0.78 | NISCH (0.46) | NISCHMTORADKMETAP2ALDH1A1 | |
| SCHEMBL24575910 | 0.76 | KDM4E (0.64) | CCR1CCR8NISCHMTORADK | |
| SCHEMBL20987228 | 0.76 | NISCH (0.63) | CCR1CCR8NISCHMTORADK | |
| SCHEMBL12075550 | 0.76 | KDM4E (0.40) | NISCHMTORADKALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137203-A1 | GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY | ABBOTT DIABETES CARE, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20250194964-A1 | GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY | ABBOTT DIABETES CARE, INC. | 2025-06-19 | — | — | US | disclosed |
| CN-117881669-A | Condensed ring heteroaryl compounds and uses thereof | 比西切姆有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-10219730-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2019-03-05 | — | — | US | disclosed |
| US-10219730-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2019-03-05 | — | — | US | disclosed |
| US-20170227690-A1 | NEAR INFRARED RAY ABSORBENT COMPOSITION, NEAR INFRARED RAY CUT FILTER, SOLID IMAGE PICKUP ELEMENT, AND CAMERA MODULE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170227690-A1 | NEAR INFRARED RAY ABSORBENT COMPOSITION, NEAR INFRARED RAY CUT FILTER, SOLID IMAGE PICKUP ELEMENT, AND CAMERA MODULE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| EP-1230248-B1 | TRANSITION METAL COMPLEXES ATTACHED TO A POLYMER VIA A FLEXIBLE CHAIN | THERASENSE INC (US) | 2007-06-06 | — | — | EP | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-6605200-B1 | Charge transfer compounds comprising polymers such as polyvinylpyridine and/or copolymers coupled to osmium compounds, used as biosensors in redox systems | THERASENSE, INC. | 2003-08-12 | — | — | US | disclosed |
| EP-1230248-A2 | TRANSITION METAL COMPLEXES ATTACHED TO A POLYMER VIA A FLEXIBLE CHAIN | Therasense, Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001036660-A2 | TRANSITION METAL COMPLEXES ATTACHED TO A POLYMER VIA A FLEXIBLE CHAIN | THERASENSE, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | LPO, TXN2, PRDX5 | CCR1 4067/4885CCR8 2735/4885NISCH 771/4885 |
| US-20170227690-A1 | NEAR INFRARED RAY ABSORBENT COMPOSITION, NEAR INFRARED RAY CUT FILTER, SOLID IMAGE PICKUP ELEMENT, AND CAMERA MODULE | C9, SET, CRY1 | CCR1 3230/4885CCR8 4074/4885NISCH 779/4885 |
| US-10219730-B2 | Redox polymers | PPOX, OTC, ME3 | CCR1 4831/4885CCR8 4512/4885NISCH 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.